Bank of America’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Bank of America’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-92,927	Closed	-$1.18M	–	8379
2014 Q3	$1.18M	Buy	92,927 +31,756	+52%	+$474K	﹤0.01%	3861
2014 Q2	$1.04M	Buy	61,171 +39,930	+188%	+$595K	﹤0.01%	3943
2014 Q1	$286K	Sell	21,241 -19,776	-48%	-$259K	﹤0.01%	5116
2013 Q4	$525K	Sell	41,017 -5,491	-12%	-$57.6K	﹤0.01%	4721
2013 Q3	$420K	Buy	46,508 +17,724	+62%	+$147K	﹤0.01%	4795
2013 Q2	$207K	Buy	+28,784	New	+$211K	﹤0.01%	5587

Bank of America's DRTX Position: Q4 2014 in Review

Bank of America sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 92,927 shares — an estimated $1.18M sold.

Bank of America first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $1.18M in Q3 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Bank of America reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Bank of America sold 92,927 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $1.18M.
Bank of America first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
Bank of America's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $1.18M in Q3 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Bank of America's 13F filing for Q4 2014, filed 13 Feb 2015.